TL;DR
Get wellness gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Huberman Lab’s episode “Overcome Addictions & Obsessions of All Kinds” features Dr. Anna Lembke, identified by the show as chief of Stanford’s Addiction Medicine Dual Diagnosis Clinic. The episode discusses dopamine, compulsive behavior, control and spiritual practices; the supplied page does not establish a release date or provide a reviewed transcript.
Huberman Lab’s episode “Overcome Addictions & Obsessions of All Kinds” features Dr. Anna Lembke, a Stanford addiction specialist, discussing dopamine, compulsive behaviors and approaches to addiction. The episode page says its transcript is under human review, leaving the full conversation’s exact wording unavailable in the supplied material.
The show identifies Lembke, an MD, as chief of the Addiction Medicine Dual Diagnosis Clinic at Stanford and describes her as an expert on addiction. Its summary says the conversation considers how dopamine dynamics relate to risk-taking, mental preoccupation and compulsive behavior. The page does not provide a detailed transcript or specific study findings from the discussion.
Other listed subjects include what the episode calls a common addiction to control, and whether prayer and spiritual practices can support changes in thought and behavior, including in codependence. These are topics attributed to the episode summary, not independently established outcomes. The page also links to Lembke’s books, including Dopamine Nation: Finding Balance in the Age of Indulgence and Radical Surrender: Letting Go in a World Addicted to Control.
The episode listing points readers to peer-support organizations including Alcoholics Anonymous, Al-Anon Family Groups and Co-Dependents Anonymous. It also includes research links on dopamine, stress and addiction, alongside other related resources. The source page cautions that its transcript is still being reviewed and may contain errors; a fully reviewed version is expected to be posted later.
A Discussion Spanning Addiction and Control
The episode brings addiction and related compulsive patterns to a broad audience through a conversation with a clinician identified as leading a Stanford dual-diagnosis clinic. That framing may interest listeners trying to understand how substance-related problems, repetitive behaviors and emotional patterns are discussed together. The episode summary, however, is not a clinical guideline and does not establish that any one practice works for every person.
Its inclusion of peer-support resources offers a practical route for listeners seeking information beyond the conversation. The distinctions matter: the listing raises subjects such as spirituality and control, but readers should not treat its brief description as proof of a treatment effect or as individualized medical advice.
Products Worth Considering

EGO Power+ SNT2420 24-Inch Two-Stage Self-Propelled Snow Blower (Battery and Charger Not Included)

DEWALT 10-Inch Jobsite Table Saw with Scissor Stand (DWE7491X)

WORX WG176 20V Cordless Brushless String Trimmer, 13–15-Inch
As an affiliate, we earn on qualifying purchases.
Episode Topics and Linked Resources
The listing places Lembke’s discussion within a wider set of Huberman Lab materials, including episodes on consciousness, religion and belief, motivation, and immune health. It also names researchers and authors whose work is connected to the episode’s subject matter. Those links provide background, but the supplied source does not say that every cited paper or person was discussed in detail during the recording.
The page recommends books by Lembke and lists groups such as AA, Al-Anon and CoDA. These organizations serve different audiences, including people seeking support for alcohol-related problems and relatives or others affected by someone’s drinking. Their appearance on the page shows that the publisher is directing readers to additional resources; it does not indicate endorsement of a particular recovery plan or confirm a specific outcome.
Huberman Lab also says a fully reviewed transcript will be posted after the current version completes human review. Until then, the program’s written summary is the clearest account supplied here of the episode’s scope. The source gives no release date, and it does not state whether the audio itself has changed or whether any transcript corrections are expected.
““We discuss dopamine dynamics in the brain and how they impact risk-taking, mental obsession, and compulsive behaviors.””
— Huberman Lab episode page
Transcript and Treatment Details Pending
The supplied page does not specify when the episode was published, provide the full recording, or include a reviewed transcript. As a result, the precise wording, examples and qualifications Lembke may have used cannot be verified from this material. The page’s summary gives subjects, not a complete account of the discussion.
It is also unclear what evidence or limits the speakers discussed around prayer, spiritual practice, control and codependence. The source does not report clinical results, make a treatment recommendation for individual listeners, or state that any of these approaches can replace professional care. Readers with concerns about substance use or compulsive behavior would need information from qualified professionals and appropriate support services.
A Reviewed Transcript Is Expected
Huberman Lab says it will post a fully reviewed transcript when the human review is complete, but gives no timetable. That version should allow readers to check the conversation’s exact claims and context against the current short summary. The episode page also promotes Huberman Lab Premium, which it says provides full transcripts and other member content; access terms are not detailed in the supplied report.
For now, the confirmed development is the episode listing and its stated subject matter. No further announcement, transcript release date or new clinical guidance appears in the source material.
Key Questions
What is the Huberman Lab episode about?
Its summary says the conversation with Dr. Anna Lembke covers dopamine, risk-taking, mental preoccupation, compulsive behavior, control and spiritual practices.
Who is Dr. Anna Lembke?
Huberman Lab identifies Lembke as an MD and chief of Stanford’s Addiction Medicine Dual Diagnosis Clinic.
Is the episode transcript final?
No. The page says the transcript is under human review and may contain errors. A fully reviewed version is expected, with no date specified.
Does the episode page give treatment advice?
The supplied summary describes topics rather than a personalized treatment plan. It lists peer-support groups, but does not establish that any approach discussed is suitable for every person.
Source: hubermanlab.com
